• Home
  • About Us
    • Company Profile
    • Mission
    • Management
    • Scientific Advisors
    • Investors
  • News
  • Partners
  • Research
  • Products
    • AquADEKs
    • Aqua-E
    • 400/400
    • Omega-T
    • Antioxidant Factor
    • Tocotrienols
    • Maxi-Gamma
    • 100/100
    • Callisto Oil
    • Callisto Creme
  • Quick Order
  • FAQs
    • Ask the Doc
    • Product FAQs
    • Ordering FAQs
    • Shipping FAQs
    • Security & Privacy
    • Accounts FAQs
    • How to Choose Which Product
    • Where to Buy
    • Yasoo Health E-Club
  • Shopping Cart
  • International
  • Contact Us


News

New help for people with CF or conditions that cause malabsorption of fat-soluble vitamins

April 23, 2007- Johnson City, TN? Yasoo Health Inc announced the U.S. launch of AquADEKsTM, a novel nutritional supplement designed to ...
Read More»

Yasoo Health; a finalist in Nutracon

March 12, 2007- AquADEKs, a product developed by Yasoo Health was selected as one of the three finalists in the 2007 Nutracon Award Competition
Read More»

Yasoo Health Ltd. is awarded a research grant from the Cyprus Research Promotion Foundation for its cancer chemoprevention research program

February 20, 2007 -Yasoo Health Ltd (Yasoo), a subsidiary of Yasoo Health Inc., reported today that it has been awarded a research grant from the Cyprus Research Promotion Foundation (RPF, www.research.org.cy) to support its research and development work on the identification and development of chemo-preventive products for the prevention and treatment of prostate cancer.
Read More»

Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation

February 7, 2006 - Yasoo Health, Inc. announced today that it received $936,375 in financing from the Cystic Fibrosis Foundation* to develop and commercialize a "first of its kind" formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis (CF) patients. 
Read More»

Yasoo Health Ltd. receives a research grant from the European organization EUREKA for its Inflammatory Bowel Disease Program

February 1, 2007 - Yasoo Health Ltd (Yasoo) announced today that it has secured a research grant from the European organization EUREKA (www.eureka.be) to support its research and development work on a product for the management and adjuvant therapy of Inflammatory Bowel Disease (IBD).
Read More»

The Health Benefits of Antioxidants

Many Americans are interested in the role of antioxidants in the prevention of disease and the maintenance of good health. 
Read More»

Yasoo Health Awarded Patent

April 6, 2004 - Press Release -Yasoo Health, Inc announced today patent protection for a novel tocopherol ester derivative with selenium and other minerals.
Read More»

Vitamin E and Health - The 2004 NYAS Conference

The New York Academy of Sciences (NYAS) held a conference on Vitamin E and Health in Boston on May 22-24th. 
Read More»


Antioxidants and Alzheimer's

Alzheimer's is the most common form of dementia, a disabling neurological disease that affects memory, thinking and the ability to conduct simple activities. 
Read More »

Yasoo Health Inc. Closes Series A Financing

July 1, 2002 - Yasoo Health Inc. (Yasoo) closed Series A financing from the Bank of Cyprus Ventures and Emergo.
Read More»

Yasoo Health Inc. Receives SBIR Grant

April 1, 2002 - Yasoo Health Inc. received funding from the NIH for a Small Business Innovation Research grant to develop formulations containing fat-soluble vitamins and nutrients (vitamins D3, K1 and mixed tocopherols (E), beta-carotene, linoleic and/or linolenic acids and coenzyme Q10) that will be administered to children with cystic fibrosis to alleviate complications due to the malabsorption of fat-soluble nutrients.
Read More»

 


Copyright © 2003 - 2007 Yasoo Health Inc. All Rights Reserved.